Biotech

Inside the discoveries, personalities, and deals driving drug development. Sign up for the Readout newsletter here.

Liver fibrosis IC
Health

CAR-T cells, better known as cancer drugs, show promise against aging in lab mice

By Sharon Begley

MORE Red Blood Cells
Biotech

BioMarin’s hemophilia gene therapy continues to prevent bleeding at four years

By Matthew Herper and Damian Garde

Sam Altman
Biotech

A tech investor’s rude awakening on clinical trials sparks an effort to make them faster for Covid-19

By Matthew Herper

IV Drip
Biotech

Momenta Pharma drug improves symptoms in patients with myasthenia gravis

By Adam Feuerstein

stat_spacerace
Biotech

What’s at stake for industry in the pharmaceutical Space Race for a Covid-19 vaccine

By Damian Garde

ASH 19 - Fluorescent osteoblast cells
Biotech

As efficacy of Constellation’s blood cancer drug wanes, the debate over its future ratchets higher

By Adam Feuerstein

Biotech

Agios drug demonstrates strong response in patients with inherited blood disorder

By Adam Feuerstein

ASH19 Sickle cell
Biotech

New data in sickle cell show biotech companies tackling disease in novel ways

By Adam Feuerstein

DNA mutation
Biotech

One of biotech’s biggest conferences grapples with how to talk about race and identity

By Kate Sheridan

Biotech

Verve, raising another $63 million, seeks to advance gene-editing treatment for heart disease

By Jonathan Saltzman — Boston Globe

Rollercoaster
Biotech

‘An extremely volatile time’: New report underscores the recent roller coaster of the biotech market 

By Kate Sheridan

Lungs on yellow
Biotech

The novel coronavirus attacks the lungs. A biotech company sees a common enzyme as key to protecting them

By Damian Garde

Money
Biotech

Medical device startup raises almost $44M to advance a less-invasive treatment for fluid in the brain

By Jonathan Saltzman — Boston Globe

Alzheimer neuron network with amyloid plaques
Biotech

As biotech drifts from amyloid hypothesis for Alzheimer’s, some see reason to cling on

By Kate Sheridan

Cambridge: Sarepta
Biotech

Sarepta’s gene therapy for limb-girdle disease shows improved muscle function after one year

By Adam Feuerstein

Nasdaq on screen
Biotech

China’s biggest-ever Nasdaq biotech IPO comes at an awkward time

By Damian Garde

Greg Mayes
Biotech

Startup developing an inhaler for seizures is acquired by UCB

By Elizabeth Cooney

Tony Coles-July2018
Biotech

Longtime executive Tony Coles on biotech, racism, and opportunities for change

By Adam Feuerstein, Damian Garde, and Rebecca Robbins

AstraZeneca building
Biotech

In a first for RNA-modifying drugs, AstraZeneca partners with startup Accent Therapeutics

By Kate Sheridan

Moderna
Biotech

Moderna released scant Covid-19 data to prevent a leak, CEO says

By Damian Garde

Biotech

Video Chat: The ASCO Recap, Live!

By Adam Feuerstein

oral squamous carcinoma cell
Biotech

Innovent starts China’s first trial of a novel cancer immunotherapy

By Jonathan Chan

Pfizer
Biotech

Pfizer to invest up to $500M in public companies with drugs in the clinic

By Damian Garde

Biotech

The 20 executives — and companies — to know in Chinese biotech

By STAT staff

ASCO for one
Adam's Take

ASCO 2020 takeaways: AstraZeneca does a star turn, KRAS fizzles, and cell therapy shows progress

By Adam Feuerstein

ASH19 Lymphoma
Biotech

Additional blood cancer responses seen with Allogene’s off-the-shelf CAR-T cells, updated study shows

By Adam Feuerstein

purple lungs ct
Biotech

AstraZeneca study results could change treatment for certain early-stage lung cancer patients

By Adam Feuerstein

coronavirus ct scan
Biotech

A biotech company tries to retrofit a lung drug to prevent Covid-19’s after effects

By Damian Garde

STAT SPOTLIGHT
Biotech

Startup Spotlight: Going after immune regulators when they cause disease instead of prevent it

By Elizabeth Cooney

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy